Multiple insider buying at Microbix Biosystems (T:MBX)

Joseph David Renner, a Director, acquired 666,667 Common Shares on a control or direction basis for registered holder Joe Renner family trust at a price of $0.600 through a prospectus or prospectus exempt offering on May 19th, 2021. The insider also acquired 333,333 Warrants with an exercise price of $0.800 for 24 months. This represents a $400,000 investment into the company's shares and an account share holdings change of greater than 100%.

Either other insiders also participated in the financing.

Microbix Biosystems is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Microbix Biosystems Inc is a Canada-based life science company and manufacturer of viral and bacterial antigens and cell, culture-based biological products and technologies. The Company has developed and acquired two technologies: Kinlytic Urokinase and LumiSort. Kinlytic Urokinase is a biologic thrombolytic drug used to treat blood clots. LumiSort is a technology for ultra-rapid and efficient sorting of somatic cells that can be used to enrich cell populations of interest. The Company's catalogue of antigens covers over 30 bacterial and viral pathogens that are implicated in maternal, pediatric, childhood, respiratory, sexually-transmitted and insect-borne diseases. Microbix Biosystems Inc. (MBX) has a high amount of executive buying compared to its small-cap peers in the market over the past three months. According to regulatory filings yesterday, nine insiders have invested a total amount of $686,000.